SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 731.24 |
Enterprise Value ($M) | 552.66 |
Book Value ($M) | 140.34 |
Book Value / Share | 2.69 |
Price / Book | 5.21 |
NCAV ($M) | 128.44 |
NCAV / Share | 2.46 |
Price / NCAV | 5.69 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.74 |
Return on Assets (ROA) | -0.39 |
Return on Equity (ROE) | -0.51 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.43 |
Current Ratio | 5.43 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 193.28 |
Assets | 205.18 |
Liabilities | 64.84 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 8.78 |
Operating Income | -114.77 |
Net Income | -104.70 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -81.07 |
Cash from Investing | 105.95 |
Cash from Financing | 53.01 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Skorpios Trust | -24.92 | ||
13G/A | Cowen Financial Products LLC | 8.30 | 198.19 | |
13G/A | Rtw Investments, Lp | 9.30 | 6.72 | |
13G/A | Lynx1 Capital Management LP | 6.60 | 10.99 | |
13G/A | Redmile Group, LLC | 5.90 | -36.99 | |
13G/A | Fmr Llc | 0.01 | -99.84 | |
13G/A | Morgan Stanley | 7.50 | 37.18 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
f UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
92,972 | 406,464 | 22.87 | |
70,277 | 187,620 | 37.46 | |
210,176 | 1,305,308 | 16.10 | |
91,290 | 955,192 | 9.56 | |
37,589 | 264,123 | 14.23 | |
(click for more detail) |
Similar Companies | |
---|---|
SPRO – Spero Therapeutics, Inc. | SRPT – Sarepta Therapeutics, Inc. |
SRRK – Scholar Rock Holding Corporation | STTK – Shattuck Labs, Inc. |
SVRA – Savara Inc. |
Financial data and stock pages provided by
Fintel.io